CoChat

Effect of metformin use on the risk and prognosis of endometrial cancer: a systematic review and meta-analysis

Open access

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Previous studies have suggested that metformin may be useful for preventing and treating endometrial cancer (EC), while the results have been inconsistent. This systematic review and meta-analysis aimed to investigate the association between metformin use and risk and prognosis of patients with EC. METHODS: PubMed, Embase, and the Cochrane Library databases were searched for observational studies evaluating the effect of metformin on EC prevention or treatment. The odds ratio (OR) was used for analyzing risks, and the hazard ratio (HR) was used for analyzing survival outcomes. A random-effects model was used for data analysis. RESULTS: Seven studies reported data on EC risk. The pooled results suggested that metformin was not significantly associated with a lower risk of EC [OR = 1.05, 95% confidence interval (CI) 0.82-1.35, P = 0.70]. For patients with diabetes, metformin showed no advantage in reducing the EC risk compared with other interventions (OR = 0.99, 95% CI 0.78-1.26, P = 0.95). Further, seven studies were included for survival analysis. The pooled data showed that metformin could significantly improve the overall survival of patients with EC (HR = 0.61, 95% CI 0.48-0.77, P < 0.05) and reduce the risk of EC recurrence (OR = 0.50, 95% CI 0.28-0.92, P < 0.05) Finally, we noted metformin was associated with significantly improving the overall survival of EC patients among diabetes (HR = 0.47; 95%CI 0.33-0.67, P < 0.05). CONCLUSIONS: This meta-analysis did not prove that metformin was beneficial for preventing EC. However, metformin could prolong the overall survival of patients with EC and reduce their risk of cancer relapse.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12885-018-4334-5

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Flow diagram of the study selection process
Fig. 1 Flow diagram of the study selection processCC BY · PubMed Central
Fig. 2 Forest plot of the association between metformin use and risk of endometrial cancer
Fig. 2 Forest plot of the association between metformin use and risk of endometrial cancerCC BY · PubMed Central
Fig. 3 Funnel plot of the included studies: a Studies presenting the association between metformin use and risk of endometrial cancer (EC). b Studies presenting an adjusted hazard ratio for the association between metformin use and overall survival of EC
Fig. 3 Funnel plot of the included studies: a Studies presenting the association between metformin use and risk of endometrial cancer (EC). b Studies presenting an adjusted hazard ratio for the association between metformin use and overall survival of ECCC BY · PubMed Central
Fig. 4 Forest plot of the association between metformin use and risk of endometrial cancer among patients with diabetes
Fig. 4 Forest plot of the association between metformin use and risk of endometrial cancer among patients with diabetesCC BY · PubMed Central
Fig. 5 Forest plot of the association between metformin use and overall survival of endometrial cancer
Fig. 5 Forest plot of the association between metformin use and overall survival of endometrial cancerCC BY · PubMed Central
Fig. 6 Forest plot of the association between metformin use and overall survival of endometrial cancer among patients with diabetes
Fig. 6 Forest plot of the association between metformin use and overall survival of endometrial cancer among patients with diabetesCC BY · PubMed Central
Fig. 7 Forest plot of the association between metformin use and recurrence of endometrial cancer
Fig. 7 Forest plot of the association between metformin use and recurrence of endometrial cancerCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 66 references

Cited by

See all 90

Metadata

Authors
Chu, D., Wu, J., Wang, K., Zhao, M., Wang, C., Li, L., & Guo, R.
Affiliations
First Affiliated Hospital of Zhengzhou University (CN)
Corresponding author
Guo, Ruixia
Venue
BMC Cancer
Published
2018-04-18
Volume
18
Issue
1
Pages
438-438
ISSN
1471-2407 (ISSN-L)
OpenAlex
W2805750517
Cited by
90
References
66
Citations by year
2026: 1 · 2025: 5 · 2024: 1 · 2023: 22 · 2022: 20 · 2021: 17 · 2020: 13 · 2019: 8 · 2018: 3
FWCI
1.01
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0/ (tdm)
Locations
  • BMC Cancer (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (31670844)
  • Program for Science and Technology Innovation Teams in Universities of Henan Province (17IRTSTHN021)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
Keywords
metformin, endometrial cancer, cancer risk, tumor recurrence, overall survival, diabetes mellitus, cancer prevention
MeSH terms
Female, Humans, Hypoglycemic Agents, Metformin, Neoplasm Recurrence, Local, Prognosis, Proportional Hazards Models, Odds Ratio, Endometrial Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of metformin use on the risk and prognosis of endometrial cancer: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1186/s12885-018-4334-5
The paper
Chu, D., Wu, J., Wang, K., Zhao, M., Wang, C., Li, L., & Guo, R. (2018). Effect of metformin use on the risk and prognosis of endometrial cancer: a systematic review and meta-analysis. BMC Cancer. https://doi.org/10.1186/s12885-018-4334-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.